These important building blocks, necessary for the development of a variety of drug candidates in a variety of therapeutic indices, are a particular specialty of ARCI’s research chemists. We offer a large catalogue of both standard and novel heterocyclics suitable for your drug discovery initiatives and structure-activity relationship (SAR) studies. Many of our novel intermediates possess structures matching Lipinski’s Rule of Fives for druglikeness, speeding up your candidate discovery process.
Among our heterocylic products, we supply:
- Five-membered heterocycles (furans, oxazoles, isooxazoles, thiophenes, thiazoles, isothiozoles, pyrroles, pyrrolidines, pyrazoles, imidazoles, triazoles, tetrazoles)
- Six-membered heterocycles (pyridines, bipyridines, piperidines, piperazines, pyrimidines, pyradazines, pyrazines, morpholines)
- Fused heterocycles (Indoles . Indazoles, azaindoles, enzothiazoles, benzooxazoles, benzodiazapines, imidazopyridines, quinolines, isoquinolines, quinozilines, quinoxalines)
- Bis-heterocyclic compounds